你即將離開本站

並前往https://www.medrxiv.org/content/10.1101/2021.12.29.21268499v1

a phase 2 randomised, double-blinded, controlled clinical trial

Safety and immunogenicity of a heterologous boost with a recombinant vaccine, NVSI-06-07, in the inactivated vaccine recipients from UAE: a ...

確定！ 回上一頁

查詢 「Recombinant vaccine」的人也找了：